Asia-Pacific consensus guidelines for endoscopic management of benign biliary strictures

Hu, Bing; Sun, Bo; Cai, Qiang; Lau, James Y.; Ma, Shuren; Itoi, Takao; Lee, Moon Sung; Yasuda, Ichiro; Zhang, Xiaofeng; Wang, Hsiu-Po; Ryozawa, Shomei; Rerknimitr, Rungsun; Li, Wen; Kutsumi, Hiromu; Lakhtakia, Sundeep; Shiomi, Hideyuki; Ji, Ming; Li, Xun; Qian, Dali; Yang, Zhuo; Zheng, Xiaojing

doi:10.1016/j.gie.2017.02.031

Cited by 61 publications

(62 citation statements)

References 120 publications

(157 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Endoscopic management is considered as a first‐line treatment for BBS because of its safety, effectiveness, and less‐invasive nature when compared with surgery or percutaneous techniques. The recently published Asian‐Pacific consensus guidelines summarized the endoscopic management of BBS . Our proposal for endoscopic management of BBS is shown in Figure .…”

Section: Methodsmentioning

confidence: 99%

International consensus statements for endoscopic management of distal biliary stricture

Nakai

Isayama

Wang

et al. 2020

J of Gastro and Hepatol

Self Cite

103

View full text Add to dashboard Cite

Distal biliary strictures (DBS) are common and may be caused by both malignant and benign pathologies. While endoscopic procedures play a major role in their management, a comprehensive review of the subject is still lacking. Our consensus statements were formulated by a group of expert Asian pancreatico‐biliary interventional endoscopists, following a proposal from the Digestive Endoscopy Society of Taiwan, the Thai Association for Gastrointestinal Endoscopy, and the Tokyo Conference of Asian Pancreato‐biliary Interventional Endoscopy. Based on a literature review utilizing Medline, Cochrane library, and Embase databases, a total of 19 consensus statements on DBS were made on diagnosis, endoscopic drainage, benign biliary stricture, malignant biliary stricture, and management of recurrent biliary obstruction and other complications. Our consensus statements provide comprehensive guidance for the endoscopic management of DBS.

show abstract

Section: Methodsmentioning

confidence: 99%

International consensus statements for endoscopic management of distal biliary stricture

Nakai

Isayama

Wang

et al. 2020

J of Gastro and Hepatol

Self Cite

103

View full text Add to dashboard Cite

show abstract

“…Biliary strictures represent a major diagnostic and management challenge, often requiring a multidisciplinary approach involving endoscopists, surgeons, radiologists, pathologists and oncologists. Once common causes of benign etiology, such as common bile duct (CBD) injury during cholecystectomy, chronic pancreatitis, primary sclerosing cholangitis, ischemic and non‐ischemic injury in the setting of liver transplantation, anastomotic disease after biliary tract surgery, and abdominal traumas have been ruled out, the most frequent cause of biliary strictures in Western countries is the presence of a malignant disease. Pancreatic head cancers, extrahepatic cholangiocarcinomas, gallbladder cancers, malignant hilar lymphadenopathy and hepatocellular carcinomas can all present with a biliary stricture …”

Section: Malignant Biliary Stricturesmentioning

confidence: 99%

Endoscopic radiofrequency biliary ablation treatment: A comprehensive review

Larghi

Rimbaș

Tringali

et al. 2019

Digestive Endoscopy

View full text Add to dashboard Cite

Radiofrequency ablation (RFA) functions by delivering thermal energy within tissue, the result of a high‐frequency alternating current released from an active electrode, leading to coagulative necrosis and cellular death. Recently, a biliary catheter working on a guidewire has been developed and a number of studies have so far been carried out. The present article provides a comprehensive review of the literature on the results of the use of RFA for the clinical management of patients with unresectable malignant biliary strictures, benign biliary strictures, and residual adenomatous tissue in the bile duct after endoscopic papillectomy. Available data show that biliary RFA treatment is a promising adjuvant therapy in patients with unresectable malignant biliary obstruction. The procedure is safe, well tolerated and improves stent patency and survival, even though more studies are warranted. In patients with residual endobiliary adenomatous tissue after endoscopic papillectomy, a significant rate of neoplasia eradication after a single RFA session has been reported, thus favoring this treatment over surgical intervention. In these patients, as well as in those with benign biliary strictures, dedicated probes with a short electrode able to focus the RF current on the short stenosis are needed to expand RFA treatment for these indications.

show abstract

“…In recent years, several studies have been conducted on endoscopic treatment of benign biliary strictures. In general, multiple plastic stent implantation is recommended for treating benign biliary strictures, and the number of reports on FCSEMS implantation has recently increased. Zheng et al .…”

Section: Endoscopic Therapy For Benign Biliary Stricturementioning

confidence: 99%

“…I N RECENT YEARS, several studies have been conducted on endoscopic treatment of benign biliary strictures. In general, multiple plastic stent implantation is recommended for treating benign biliary strictures, 36 and the number of reports on FCSEMS implantation has recently increased. Zheng et al 37 performed systematic review and meta-analysis, reported that placement of CSEMS was effective in the treatment of benign biliary stricture with relatively short stenting duration and low long-term stricture recurrence rate.…”

Section: Endoscopic Therapy For Benign Biliary Stricturementioning

confidence: 99%

Recent innovations in therapeutic endoscopy for pancreatobiliary diseases

Irisawa¹,

Miyoshi

Itoi

et al. 2019

Digestive Endoscopy

Self Cite

View full text Add to dashboard Cite

The development of endoscopic treatment for pancreatobiliary diseases in recent years is remarkable. In addition to conventional transpapillary treatments under endoscopic retrograde cholangiopancreatography (ERCP), new endoscopic ultrasound‐guided therapy is being developed and implemented. On the other hand, due to the development/improvement of various devices such as new metal stents, a new therapeutic strategy under ERCP is also advocated. The present review focuses on recent advances in the endoscopic treatment of pancreatic pseudocysts, walled‐off necrosis, malignant biliary strictures, and benign biliary/pancreatic duct strictures.

show abstract

Asia-Pacific consensus guidelines for endoscopic management of benign biliary strictures

Cited by 61 publications

References 120 publications

International consensus statements for endoscopic management of distal biliary stricture

International consensus statements for endoscopic management of distal biliary stricture

Endoscopic radiofrequency biliary ablation treatment: A comprehensive review

Recent innovations in therapeutic endoscopy for pancreatobiliary diseases

Contact Info

Product

Resources

About